| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 22 |
| Opened positions | 2 |
| Closed positions | 11 |
| Increased positions | 2 |
| Reduced positions | 3 |
| 13F shares | Current |
|---|---|
| Total value | 16.67 bn |
| Total shares | 33.62 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| AZN AstraZeneca | 16.00 mm | $40.96 mm |
| Bpifrance Participations | 6.91 mm | $20.95 mm |
| Long Focus Capital Management | 4.62 mm | $9.88 bn |
| PFE Pfizer | 2.79 mm | $8.22 mm |
| Capital International Investors | 1.85 mm | $3.96 bn |
| Baillie Gifford & Co | 693.94 k | $1.49 bn |
| PFG Principal Financial | 411.80 k | $881.25 mm |
| KBCSF KBC | 163.45 k | $347.00 k |
| LPL Financial | 92.37 k | $195.83 mm |
| First Affirmative Financial Network | 21.09 k | $44.84 mm |
